FDA accepts Duramed’s Lo Seasonique NDA

Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals has reported that the FDA has accepted for review its new drug application or NDA for Lo Seasonique extended-cycle oral contraceptive.